Funding for this research was provided by:
Steven and Alexandra Cohen Foundation (SACF CU15-4008, CF CU18-2692)
National Institute of Allergy and Infectious Diseases (1ZIAAI000695)
Received: 23 April 2020
Accepted: 15 July 2020
First Online: 24 July 2020
Ethics approval and consent to participate
: De-identified sera collected from patient with Lyme disease and onchocerciasis were obtained under clinical protocols (ClinicalTrials.gov Identifier NCT00028080, NCT00001539 and NCT00001230) approved by the institutional review board of the National Institute of Allergy and Infectious Diseases, and all participants signed informed consent. De-identified samples from patients with babesiosis and sera from <i>Peromyscus leucopus</i> were kindly provided by Dr Azad Gucwa and Dr Sam Telford, respectively.
: Not applicable.
: The authors declare that they have no competing interests.